| ■ 영문 제목 : Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00159 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 83 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 만성폐색성 폐질환 관련 개입성 폐질환의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (핫스팀 어블레이션, 멤브렌 플랩테라피)와 용도별 시장규모 (클리닉, 병원, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 만성폐색성 폐질환 관련 개입성 폐질환 시장 점유율 - 지역별 만성폐색성 폐질환 관련 개입성 폐질환 시장규모 - 주요지역의 종류별 시장규모 (핫스팀 어블레이션, 멤브렌 플랩테라피) - 주요지역의 용도별 시장규모 (클리닉, 병원, 기타) - 미주의 만성폐색성 폐질환 관련 개입성 폐질환 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 만성폐색성 폐질환 관련 개입성 폐질환 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 만성폐색성 폐질환 관련 개입성 폐질환 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 만성폐색성 폐질환 관련 개입성 폐질환 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 만성폐색성 폐질환 관련 개입성 폐질환 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Pulmonx, Olympus, Boston Scientific Corporation - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease will have significant change from previous year. By the most conservative estimates of global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Hot Steam Ablation
Membrane Flap Therapy
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Clinics
Hospitals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pulmonx
Olympus
Boston Scientific Corporation
1 Scope of the Report 2 Executive Summary 3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Players 4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Hot Steam Ablation Table 3. Major Players of Membrane Flap Therapy Table 4. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size CAGR by Type (2020-2026) & ($ Millions) Table 5. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) & ($ Millions) Table 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2021) Table 7. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size CAGR by Application (2016-2021) & ($ Millions) Table 8. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) & ($ Millions) Table 9. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2021) Table 10. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue by Players (2019-2021E) & ($ Millions) Table 11. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2019-2021E) Table 12. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Key Players Head office and Products Offered Table 13. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Regions 2016-2021 & ($ Millions) Table 17. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Regions 2016-2021 Table 18. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & ($ Millions) Table 19. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Country (2016-2021) Table 20. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) & ($ Millions) Table 21. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2021) Table 22. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) & ($ Millions) Table 23. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2021) Table 24. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021) & ($ Millions) Table 25. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Region (2016-2021) Table 26. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) & ($ Millions) Table 27. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2021) Table 28. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) & ($ Millions) Table 29. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2021) Table 30. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & ($ Millions) Table 31. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Country (2016-2021) Table 32. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) & ($ Millions) Table 33. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2021) Table 34. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) & ($ Millions) Table 35. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2021) Table 36. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021) & ($ Millions) Table 37. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Region (2016-2021) Table 38. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) & ($ Millions) Table 39. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2021) Table 40. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) & ($ Millions) Table 41. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2021) Table 42. Key and Potential Regions of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Table 43. Key Application and Potential Industries of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Table 44. Key Challenges of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Table 45. Key Trends of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Table 46. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 47. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share Forecast by Regions (2021-2026) Table 48. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2021-2026) & ($ Millions) Table 49. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share Forecast by Type (2021-2026) Table 50. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Forecast by Application (2021-2026) & ($ Millions) Table 51. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share Forecast by Application (2021-2026) Table 52. Pulmonx Details, Company Type, Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Area Served and Its Competitors Table 53. Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product Offered Table 54. Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 55. Pulmonx Main Business Table 56. Pulmonx Latest Developments Table 57. Olympus Details, Company Type, Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Area Served and Its Competitors Table 58. Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product Offered Table 59. Olympus Main Business Table 60. Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 61. Olympus Latest Developments Table 62. Boston Scientific Corporation Details, Company Type, Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Area Served and Its Competitors Table 63. Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product Offered Table 64. Boston Scientific Corporation Main Business Table 65. Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 66. Boston Scientific Corporation Latest Developments List of Figures Figure 1. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type in 2020 Figure 7. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease in Clinics Figure 8. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market: Clinics (2016-2021) & ($ Millions) Figure 9. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease in Hospitals Figure 10. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market: Hospitals (2016-2021) & ($ Millions) Figure 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease in Others Figure 12. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market: Others (2016-2021) & ($ Millions) Figure 13. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application in 2020 Figure 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Player in 2020 Figure 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Regions (2016-2021) Figure 16. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2016-2021 ($ Millions) Figure 17. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2016-2021 ($ Millions) Figure 18. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2016-2021 ($ Millions) Figure 20. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Country in 2020 Figure 21. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type in 2020 Figure 22. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application in 2020 Figure 23. United States Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Regions in 2020 Figure 27. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type in 2020 Figure 28. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application in 2020 Figure 29. China Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 33. India Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Country in 2020 Figure 36. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type in 2020 Figure 37. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application in 2020 Figure 38. Germany Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 39. France Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Market Share by Application in 2020 Figure 46. Egypt Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 52. APAC Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 53. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 55. United States Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 56. Canada Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 57. Mexico Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 58. Brazil Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 59. China Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 60. Japan Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 61. Korea Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 63. India Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 64. Australia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 65. Germany Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 66. France Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 67. UK Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 68. Italy Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 69. Russia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 70. Spain Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 71. Egypt Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 72. South Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 73. Israel Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 74. Turkey Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 만성폐색성 폐질환 관련 개입성 폐질환 시장예측 2021년-2026년] (코드 : LPI-2201K00159) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 만성폐색성 폐질환 관련 개입성 폐질환 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |